Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Recent Patents on Nanotechnology|March 14, 2020
Antibiofilm Action of ZnO, SnO2 and CeO2 Nanoparticles Towards Grampositive Biofilm Forming Pathogenic BacteriaFazlurrahman Khan, Jang-Won Lee, Dung N T Pham, et al.Endocrinology|September 6, 2005
Cloning, expression, and localization of MNAR/PELP1 in rodent brain: colocalization in estrogen receptor-alpha- but not in gonadotropin-releasing hormone-positive neuronsMohammad M Khan, Martin Hadman, Chandramohan Wakade, et al.Experimental Neurology|May 11, 2016
Motor phenotypes and molecular networks associated with germline deficiency of Ciz1Jianfeng Xiao, Satya R Vemula, Yi Xue, et al.American Journal of Physiology. Heart and Circulatory Physiology|February 13, 2007
Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivoSarmina Hassan, Irma M Sainz, Mohammad M Khan, et al.Neurobiology of Disease|November 29, 2016
Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndromeJianfeng Xiao, Satya R Vemula, Yi Xue, et al.Journal of Neurological Surgery Reports|July 14, 2025
Cisternal Neurocysticercosis: A Systematic Review and Meta-Analysis of Therapeutic Efficacy, Safety, and OutcomesAmmar A Elsayed, Abbas F A Hussein, Yousef H Saad, et al.Journal of Neurological Surgery Reports|August 14, 2025
Erratum: Cisternal Neurocysticercosis: A Systematic Review and Meta-Analysis of Therapeutic Efficacy, Safety, and OutcomesAmmar A Elsayed, Abbas F A Hussein, Yousef H Saad, et al.Neurotoxicology|October 16, 2014
Sesamin attenuates neurotoxicity in mouse model of ischemic brain strokeSaif Ahmad, Nehal M Elsherbiny, Rizwanul Haque, et al.Human Molecular Genetics|January 5, 2018
A recurrent de novo missense mutation in UBTF causes developmental neuroregressionCamilo Toro, Roderick T Hori, May Christine V Malicdan, et al.International Journal of Cancer|April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)Nicholas D James, Noel W Clarke, Adrian Cook, et al.Pageof 4